News
Fluent BioSciences Releases Comprehensive White Paper Highlighting Increased Performance Metrics with the Latest v4.0 PIPseq™ Single Cell 3′ RNA Sequencing Kits
Fluent BioSciences, a leading life sciences company focused on revolutionizing single cell analysis through simple, cost effective and scalable solutions, has published a white paper highlighting the performance improvements of the recently announced v4.0 chemistry as compared to the previous v3.0 chemistry. The v4.0 chemistry enables users to achieve higher capture rates, significantly higher sensitivity […]
Nature Biotechnology Journal showcases PIPseq™ scRNA-Seq Technology
Fluent BioSciences announces Nature Biotechnology journal publication, “Microfluidics-free single-cell genomics with templated emulsification” Showcases the foundational technology underlying PIPseq™ The Nature Journal publication follows the recent release of Fluent’s v4.0 chemistry with significant performance enhancements and the highest cell capture rate in the market. Watertown, MA, March 7, 2023 – Fluent BioSciences, a leading life […]
Fluent BioSciences announces PIPseq™ v4.0 for Single Cell Analysis
PIPseq™ v4.0 chemistry with significant performance enhancements and the highest cell capture rate in the single cell market announced at the 2023 AGBT conference Fluent will be presenting a poster highlighting the PIPseq technology and customer case studies of projects enabled by the highly scalable portfolio of 3′ Single Cell RNA Kits WATERTOWN, Mass., Feb. 6, […]
Fluent BioSciences Showcasing Breakthrough Solutions at the 2022 ASHG Conference
The PIPseq™ portfolio of kits enable any researcher to easily perform a broad range of single-cell transcriptomic applications in a single reaction with no expensive capital equipment Watertown, MA, October 25, 2022 – Fluent BioSciences, a life sciences company focused on making single-cell analysis simple and accessible to every researcher, announced it will be presenting […]
Fluent BioSciences launches industry’s first single tube 100,000 cell product to enable unprecedented scale, cost-efficiency and access for single-cell RNA sequencing
The PIPseq™ T100 kits enable any researcher to easily perform large, complex single-cell transcriptomic applications in a single reaction with no expensive capital equipment Watertown, MA, September 27, 2022 – Fluent BioSciences, a life sciences company focused on making single-cell analysis simple and accessible to every researcher, announces the launch of a novel 100,000 cell […]
Fluent BioSciences launches industry’s most accessible, cost-effective and scalable technology (PIPseq™) to accelerate adoption of single-cell RNA sequencing in any laboratory
Priced as low as $300 per reaction, the T2 and T20 kits enable any researcher to immediately access the power of single-cell transcriptomics with no capital investment WATERTOWN, Mass., June 23, 2022 /PRNewswire/ — Fluent BioSciences, a biotechnology company focused on making single-cell analysis simple and accessible to every researcher, announced the launch of two new breakthrough products for […]
Fluent BioSciences and NanoCellect Collaborate to Improve scRNA-Seq Analysis
Fluent BioSciences and NanoCellect announce joint collaboration to improve resolution of single-cell RNA sequencing analysis of rare cell populations Watertown, MA, June 17, 2022 – Fluent BioSciences, a biotechnology company focused on making single-cell analysis simple and accessible to every researcher, and NanoCellect Biomedical, Inc., a leader in the development and manufacturing of innovative and […]
Fluent BioSciences expands access to industry’s most flexible and scalable technology (PIPseq) to enable sensitive single-cell transcriptome analysis in any laboratory
Watertown, MA., May 5, 2022 – Fluent BioSciences, a biotechnology company focused on making single-cell analysis simple and accessible to every researcher, announced expanded early access to two new products for 3′ single-cell RNA analysis. Scaled to efficiently and effectively meet diverse experimental demands, PIPseqTM T2 and T20 kits capture up to 2,000 and 20,000 […]
Fluent BioSciences awarded $1.7 Million SBIR grant to commercialize PIPseq™ a breakthrough platform technology enabling scalable, sensitive single-cell analysis in any laboratory
Funding will be used to support commercialization of single-cell RNA sequencing (scRNA-Seq) products and services to address the critical need for accessibility, affordability and scalability. Watertown, MA., March 9, 2022 – Fluent BioSciences, a biotechnology company focused on making single-cell analysis simple and accessible to every researcher, announced today that it has been awarded a […]